Partner Spotlight

TruMed Systems, the maker of AccuVax and AccuShelf would like to help you establish a robust COVID-19 infrastructure today. The AccuShelf system ensures compliance by simplifying complex COVID-19 workflows and protects vaccine integrity.  Their new promotion, “Be COVID-19 Ready with AccuShelf TM-C – The Complete Vaccine Management System for COVID-19” addresses customer questions on the COVID-19 vaccine and how they can be ready! What better way to ease your concerns and show how simple it is to manage the COVID-19 vaccine storage and workflows than with AccuShelf!

For only $250 per month, this offer includes:

·     AccuShelf Temperature Monitoring System with wireless scanner

·     x1 ultra-low temperature digital data logger

·     X2 standard temperature digital data loggers

·     Automated COVID-19 vaccine workflows with expiry tracking and real-time dose tracking

·     Management and workflows for all vaccines

Please reach out to to schedule a demonstration.

Welcome New Referral Partner

Adaptive Medical Partners joins APHCA as a new referral partner. We’re excited for this new partnership and all that will come from it. Read more about them below.

Your journey to the right recruiting partner starts here. Physician recruiting is more difficult than it has ever been. Working with over 100 FQHC’s across the country, Adaptive Medical Partners is here to simplify recruiting, source quality candidates, and help you invest confidently.

I would recommend Adaptive Medical as a recruitment company each and every time you are left to fill any high priority staffing vacancies. The only thing we can do to improve on the process with future vacancies would be to call them sooner.” Gayanne Williams, CEO, Citizens of Lake County for Health Care Inc.

Your recruitment efforts matter, and it’s why we have a team of recruiters with an average of 11 years of experience recruiting to FQHC’s. Blend that with cutting edge technology, a leadership team that truly cares about their clients, and you’ve found a long term partner.


Referral Partner Spotlight

Doximity, the professional medical network, has acquired THMED, a leading healthcare staffing solutions company. THMED has changed its name to Curative to reflect the new company empowered by Doximity’s technology and network. Together, the two companies have created a first-ever business model for healthcare staffing that uses technology to re-engineer delivery by focusing on personalized search that connects medical groups and healthcare facilities with a far-reaching network of highly qualified vetted practitioners. Jeff Bowling will lead the company as Curative’s CEO.

Curative will serve as the staffing vertical of the largest community of healthcare professionals in the world. In the U.S. alone, over 70% of all doctors and 45% of all nurse practitioners and physician assistants are part of the Doximity network. Combining Doximity’s data science and intelligence with the service of Curative’s customer-focused recruiters empowers the company to deliver even faster and more precise personalized matching of healthcare professionals with opportunities.

“The combination of Doximity and Curative brings together tech and team in a new way that will deliver talent to our healthcare clients quickly and at scale. Also, one of the biggest wins of this deal is Jeff Bowling coming on board as the Curative CEO. Jeff’s future-forward leadership style, the value he places on people, and his record of driving growth is unmatched. His approach aligns perfectly with our culture. Together, we’re thrilled to bring this new healthcare staffing model to market,” said Jeff Tangney, CEO and co-founder of Doximity.

Bowling most recently served as founder and CEO of The Delta Companies, where he led the company to become one of the largest providers of locum tenens (temporary) in the U.S., ultimately resulting in one of the healthcare staffing industry’s biggest acquisitions. He currently holds several board positions with organizations throughout the staffing industry, including the American Staffing Association (ASA) and ClearlyRated.

Moving forward, Curative is positioned for significant growth. Bowling said, “We are going to go fast and grow fast. Curative now has all the advantages of a Silicon Valley tech company to fuel its customer experience and delivery. Most staffing firms have a database; we have access to a living, breathing network of physicians. Now, with the creation of Curative and the power of Doximity, hospitals and medical practices have access to the largest network of physicians. I’m here because this is different; 100% unique in staffing. Every CEO dreams of leading an organization with a true differentiator, and we have a clear one here.”

Former THMED brands including Medestar, Fidelis, THMED Executive Search and CV Staff Solutions are now part of the Curative brand. John Martin, former CEO of Medestar, and Arthur Cooper, former CEO of Fidelis, will remain with the company leading the locum tenens and permanent placement services, respectively.

THMED was a portfolio company of Waveland NCP Texas Ventures (WNCP), a partnership between New Capital Partners and Waveland Ventures. WNCP was a founding investor in THMED alongside John Martin.

Now live, the Curative brand reflects the forward-moving direction of the company through the expansion of the physician network and tech-forward solutions. The elements of the logo represent this next step in evolution for physician talent, exemplified by waves in motion that reverberate from the “C” in the Curative mark. To see Curative’s new look, click here.

About Doximity

Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit

About Curative

Curative finds incredible healthcare practitioner talent with less hassle using better data. We combine the heart and hard work of experienced recruiters with the intelligent technology of Doximity, the world’s largest professional medical network. Using a tech lens to re-engineer the healthcare staffing delivery model, Curative delivers a superior clinician user experience and comes through with vetted practitioners. The result: the commitment and ability to find people who care.

For more information, visit and follow us at, and


SOURCE Doximity

APHCA Partner Spotlight

Having Telehealth Technology Troubles? A new telehealth solution is available from Aesto Health, one of our Platinum Partners. Making telehealth work means making the experience easy for both patients and providers. The problem is, “easy” isn’t the same for everyone. Some of us prefer downloading apps to our mobile device, while others find using a web browser more friendly. Everyone wins when they can choose their own path to “easy.”

The telehealth solution from Aesto Health has both versions of “easy” built right in. That’s why it’s a better telehealth platform for patients and providers alike. Aesto Health offers a secure, simple and flexible solution for telehealth with an amazing patient and provider experience, automated interactions to minimize effort and robust features to enable remote monitoring of patient vitals. It’s time to upgrade your telehealth experience and stress less with the technology. Get a personal demonstration. Go to

APHCA Partner Spotlight

APCHA Partner, LabCorp, shared Wednesday about their antibody tests. Please note there has been an update to their notification time period. More information can be found below.


The below test(s) have an emergency change taking place.

Due to this, our normal notification time period will not occur. This test master notification letter indicates an emergency change.

Orderable Number and Name of test changing:
164055 SARS-CoV-2 Antibody, IgG
164034 SARS-CoV-2 Antibody, IgM
164072 SARS-CoV-2 Antibody, IgA

Reason for emergency change:
Reflex changes to IgG to support multiple platforms
Verbiage changes to IgG, IgA, and IgM for a more consise report.

Date of change: Monday 4/27/2020

Please log into and enter date parameters below to view the Emergency test changes.

LabCorp’s online Test Change Notification tool will transition to a new website called LabCorp Link™. LabCorp Link is a suite of e-services from LabCorp – linking users to one place to access the tools used every day.

To use this new system and receive current test updates and new test releases, users will need to create a LabCorp Link account. Once an account has been created, you can access Test Change Notifications for the account tied to the user ID.

Register for LabCorp Link by
For your convenience, options to access or receive test updates are provided below. Updates are posted daily and are accessible 24/7.

On LabCorp Link, click the Test Change Notification card in the dashboard. Initiate a search, populating the appropriate field with posted dates 04/20/2020-04/20/2020 and effective dates 04/27/2020-04/27/2020. You have the option to apply a filter limiting the test updates viewed. An option is also available to view all Directory of Services test updates.

APHCA Partner Spotlight

To all our healthcare partners:

We want to thank you for your dedication and perseverance during these extraordinary times. All of the employees at Medline appreciate and are inspired by what you and your teams are doing to provide care at such a critical time. Our whole country owes you a debt of gratitude.

We know that you need action and, most specifically, supplies. Medline’s designation as a Critical Infrastructure Industry is allowing us to not only stay operational, but to continue to get deliveries to all areas of the country. We are intent on doing our part to support you. We’ve increased production, redeployed and added manufacturing capabilities to produce new product and decontaminate N95 respirators for re-use, and are continuing to invest heavily in airfreighting product from Asia to increase supply as quickly as possible. We know there is not enough PPE on the ground today and want you to know Medline is sparing no cost or effort to respond to your needs.

Medline is dedicated to providing you transparent communication on the current state of product availability and how we are managing the supply chain during this crisis. In addition to the information that we’ve already shared, we are launching a resource center on in the coming days for regular updates and a host of other tools you should find beneficial as you manage through the current situation.

To find out more, please watch this video from Medline CEO Charlie Mills. On behalf of our 17,000+ employees in the United States, many of whom are working around the clock in our manufacturing and distribution centers, we are here to support you — and your patients — in every way we can.

APHCA Partner Spotlight

A message from APHCA partner, Henry Schein:

No doubt these are challenging times for all in the medical field.  We want you to know that we are here to help in any way possible as we navigate these uncharted waters together.

As you know President Trump mentioned on March 13, 2020, that the administration is releasing funds to help clinicians utilize new technologies for Telemedicine.

Telehealth is here and virtual visits can truly play a big part in practitioner consultation with their sick patients and limit any risks/spread of any viral infections to the population.  It is important to note that Henry Schein is not a Telemedicine Start up as we have been selling this solution for many years.  I encourage you to watch this short 90 second video to learn more.

Medpod is a telemedicine platform that comes in highly versatile configurations including a cloud based version without devices and complete units deployed in a suitcase, standalone cart, or a mobile facility.  This is NOT a purchase of hardware or software – you just need a web-based browser and patient care is at your fingertips.

Please click here for more information or reach out to Jason Graham at 334.538.5099 or

COVID-19 Information and Courses Available at Medline University

APHCA Platinum Partner, Medline Industries, offers APHCA members pertinent COVID-19 information through its online training tool, Medline University.  Medline extends the COVID-19 courses through its collaboration with Healthstream at no cost to health centers.  Follow the link below to Medline University.

If you have questions or medical supply needs please contact Greg Smith, Vice President Community and Rural Health at his direct line (502) 836-7908 or

Register Here

Information from LabCorp about Coronavirus Disease 2019 (COVID-19)

On March 5, 2020, LabCorp announced that its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test will be available today, beginning at 6 p.m. ET, for ordering by physicians or other authorized healthcare providers anywhere in the U.S. For more information, please review the press release.

“We have been intensely focused on making testing for COVID-19 available as soon as possible, working with the government and others to address this public health crisis,” said Adam H. Schechter, president and CEO of LabCorp. “By expanding access to testing in the U.S., and preparing to support the development of vaccines and treatments for COVID-19 through our Covance Drug Development business, we are delivering on LabCorp’s mission to improve health and improve lives.”

Coronavirus Disease 2019 (COVID-19) is a respiratory disease caused by infection with a new form of coronavirus (SARS-CoV-2) that has now been detected in multiple locations around the world, including the U.S.

On January 30, 2020, the World Health Organization declared the outbreak a “public health emergency of international concern” (PHEIC). On January 31, 2020, U.S. Department of Health and Human Services Secretary Alex M. Azar II declared a public health emergency (PHE) for the United States to aid the nation’s healthcare community in responding to COVID-19.

LabCorp’s focus is on the well-being and safety of our employees and patients, supporting business continuity for us and our customers, and assisting the global response. We are in close contact with public health authorities, and we will continue to monitor this situation and adjust our response as may be necessary or required.

On March 4, 2020, LabCorp joined with colleagues from the American Clinical Laboratory Association (ACLA) for a meeting with Vice President Pence and members of the White House’s Coronavirus Task Force. As an industry, clinical labs have taken steps to meet the growing demand for national testing and are part of a newly-formed consortium working together with the Administration, the CDC and FDA as well as state and local public health labs, hospitals and academic medical centers.

Important Information for Patients and Healthcare Providers related to testing for COVID-19:

  1. Effective on March 5, 2020 at 6 p.m. ET, physicians and other healthcare providers anywhere in the U.S. can order the LabCorp 2019 Novel Coronavirus (COVID-19), NAA test. The test detects the presence of the underlying virus that causes COVID-19 and is for use with patients who meet current guidance for evaluation of infection with COVID-19, which is available here.
  2. LabCorp does not currently collect specimens for COVID-19 testing. Patients for whom testing has been ordered should not be sent to a LabCorp location to have a specimen collected.
  3. COVID-19 testing requires a nasopharyngeal (NP) swab in viral transport medium, bronchial washings or bronchoalveloar lavage (BAL) specimen, which are collected from the nose, throat or lungs, and must be collected by a healthcare provider.
  4. Patients who are concerned that they or a family member are exhibiting symptoms of COVID-19 should immediately contact their healthcare provider to determine their next steps.
  5. Individuals seeking testing for COVID-19 should not visit a LabCorp location to request a test. Tests must be ordered by a physician or other authorized healthcare provider.
  6. Healthcare providers should contact their local or state public health authority to obtain guidance on managing patients who may have COVID-19, and about how to access testing for those patients.
  7. LabCorp can collect, transport, process and test specimens, for lab tests other than COVID-19 from patients who are confirmed positive for, or are suspected of having, COVID-19.
  8. Please review the CDC website  for the most-current information about COVID-19. State or local health authorities may also have information available.